Aridis Pharmaceuticals Correlations
| ARDSDelisted Stock | USD 0.27 0.02 8.00% |
The current 90-days correlation between Aridis Pharmaceuticals and Akari Therapeutics PLC is -0.02 (i.e., Good diversification). The correlation of Aridis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Aridis Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Aridis Pharmaceuticals and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Aridis |
The ability to find closely correlated positions to Aridis Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aridis Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aridis Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aridis Pharmaceuticals to buy it.
Moving together with Aridis Pink Sheet
Moving against Aridis Pink Sheet
| 0.56 | MBRX | Moleculin Biotech | PairCorr |
| 0.52 | MGNX | MacroGenics | PairCorr |
| 0.49 | MBIO | Mustang Bio | PairCorr |
| 0.49 | DNLI | Denali Therapeutics | PairCorr |
| 0.48 | VANI | Vivani Medical | PairCorr |
| 0.4 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.39 | MEIP | MEI Pharma | PairCorr |
| 0.59 | DTIL | Precision BioSciences | PairCorr |
| 0.54 | VERA | Vera Therapeutics | PairCorr |
| 0.5 | MLEC | Moolec Science SA | PairCorr |
| 0.5 | MNKD | MannKind Corp | PairCorr |
| 0.4 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.35 | MLYS | Mineralys Therapeutics, | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aridis Pink Sheet performing well and Aridis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aridis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AKTX | 5.70 | (0.81) | 0.00 | (55.19) | 0.00 | 11.21 | 47.27 | |||
| ADTX | 5.82 | (2.64) | 0.00 | 3.88 | 0.00 | 7.69 | 35.15 | |||
| ABVC | 3.54 | (0.31) | 0.00 | 1.12 | 0.00 | 7.55 | 25.34 | |||
| ACST | 3.00 | 0.45 | 0.09 | (0.22) | 2.83 | 9.42 | 25.09 | |||
| SGTX | 14.93 | 6.50 | 0.72 | (1.10) | 6.43 | 12.46 | 442.39 | |||
| RVPH | 6.84 | 1.19 | 0.13 | 0.85 | 8.32 | 18.87 | 71.13 | |||
| ZVSA | 5.44 | (0.42) | 0.00 | (0.06) | 0.00 | 13.76 | 78.93 | |||
| KRBP | 6.00 | (0.32) | 0.00 | (0.08) | 0.00 | 12.04 | 65.24 | |||
| UNCY | 4.77 | 0.66 | 0.12 | 0.59 | 4.87 | 14.00 | 29.86 | |||
| ATXI | 3.68 | (0.66) | 0.00 | (0.71) | 0.00 | 6.74 | 35.18 |
View Aridis Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Aridis Pharmaceuticals Corporate Management
| Vu Truong | CEO, Founder | Profile | |
| Hasan MD | Chief Officer | Profile | |
| JD Esq | Acting Counsel | Profile | |
| MBA JD | Chief Officer | Profile |
Still Interested in Aridis Pharmaceuticals?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.